EDITORIAL BOARD MEMBER - Dr. Zoran M. Todorovic
Dr. Zoran Todorovic Study of Medicine (1983-89.), master and PhD thesis at the Univ. of Belgrade, Serbia (FMUB). Specialization and sub-specialization in Clinical Pharmacology, FMUB. Postdoc (1999/2000 and 2001/2002, 12 months) at the William Harvey Research Institute, London, UK (Prof. C. Thiemermann). Full Professor of Pharmacology, Clinical Pharmacology and Toxicology (since 2008). Visiting Professor, Icahn School of Medicine at Mount Sinai, NYC (2017). Former Chairman of Pharmacology, Clinical Pharmacology and Toxicology, FMUB, Serbia (2006-2012). Clinical pharmacologist at the tird level hospital. Clinical trial experience: more than 10 phase III/IV studies (role: clinical pharmacologist). More than 300 publications (more than 40 CC/SCI in extenso publications), editor of the international monograph and more than 400 citations in CC/SCI journals. Completed research and education support: National Coordinator, European Pharmacology Thematic Network EPHARNET (EU Socrates), directed by Prof. I. Hughes, UK; the Royal Society Grant (2001-2002). Ongoing research support: Ministry of Science of Montenegro, Project Leader; NIH Project 1R25TW008171-01A1, Participant; Serbian Republic Fund, Co-Investigator, 1990-present. Among other academic and administrative responsibilities, he currently serves as President of the Bioethics Society of Serbia, and member of the National HERE Team (Higher Education Reform Experts).
Renal ischemia-reperfusion injury, cardiovasculat pharmacology, antibiotics, pharmacovigilance, bioethics